Journal of Natural Products
Article
Scheme 3. Biosynthesis of Diterpenes in E. fusca with Proposed Origin of Eunicidiol (1)
was added and the reaction was left to stir overnight at room
temperature. The reaction mixture was concentrated under a stream of
N2 and eluted through a plug of C18 using MeOH. The filtrate was
evaporated in vacuo to provide the reaction crude, which was separated
by C18 RP-HPLC using a gradient of MeOH/H2O (90:10 for 5 min,
increasing linearly to 100:0 at 30 min, 3.0 mL/min, 6/7 tR 15.2 min).
For 6: HRESIMS m/z 489.2980 [M + Na]+ (calcd for C30H42O4Na,
489.2975). For 7: HRESIMS m/z 489.2973 [M + Na]+ (calcd for
C30H42O4Na, 489.2975). See Figures S11 and S12 for 1H NMR spectra
of 6 and 7. Product yields could not be determined with accuracy owing
to the small scale of the reactions.
Table 2. Reduction of PMA-Induced Mouse Ear Edema by
Diterpenes 1−3
ab
,
group
dosage (mg/ear)
reduction of ear edema (%)
c
indomethacin
eunicidiol (1)
fuscol (2)
3.0
0.1
0.1
0.1
51.4 2.7
c
44.4 3.2
c
46.3 3.7
c
eunicol (3)
53.7 4.9
a
b
Data are presented as the mean SEM. Percent reduction of ear
c
edema is relative to the control group. Statistically significant difference
relative to the control group, unpaired Student’s t-test (p < 0.05).
Semisynthesis of Fuscol (2). A purified sample of eunicol (3)
(1.01 mg, 3.49 μmol) was refluxed in toluene for 2.5 h and evaporated in
vacuo. Analysis of the reaction crude by NMR revealed the formation of
fuscol (2) (1.28 μmol, 38%), which was later purified by C18 RP-HPLC
(MeOH/H2O, 88:12, 3.0 mL/min, tR 25.6 min). Semisynthetic fuscol
Analysis of samples by LC with hyphenated MS-ELSD-UV was
performed using a Finnigan LXQ ion trap mass spectrometer and an
analytical C18 RP-HPLC column.
(2): [α]25 = +28.8 (c 0.02 in CHCl3). Isolated fuscol (2): [α]25
=
D
D
Isolation of Fuscol (2) and Eunicol (3). E. fusca was collected from
Hillsboro Ledge, Florida by scuba, air-dried at the surface, and kept
frozen during transportation. The identity of each coral was confirmed
by comparing the TLC profile to that of a pure sample of 2. After
lyophilization, the gorgonians (124.6 g) were exhaustively extracted with
DCM, and the combined extracts were concentrated to provide a
viscous oil (11.47 g). The crude extract was initially partitioned between
hexanes and MeOH/H2O (9:1); afterward the hexanes layer was
evaporated (6.319 g) and separated by vacuum flash chromatography
using a stepwise gradient elution with hexanes/EtOAc. The hexanes/
EtOAc (4:1) fraction (592.0 mg) contained 2 and 3 according to LC-MS
analysis. This fraction was separated by C18 RP-MPLC (MeOH/H2O
gradient) to provide a mixture of 2 and 3 (289.9 mg, 2.3% of dry coral
weight). The diterpenes were separated by phenylhexyl RP-HPLC
(MeOH/H2O, 87:13, 3.0 mL/min, 2 retention time (tR) 24.8 min, 3 tR
26.7 min) and further purified by C18 RP-HPLC (MeOH/H2O, 83:17,
3.0 mL/min, 2 tR 37.6 min, 3 tR 39.6 min). For 2: HRESIMS m/z
311.2346 [M + Na]+ (calcd for C20H32ONa, 311.2345). For 3:
HRESIMS m/z 311.2346 [M + Na]+ (calcd for C20H32ONa, 311.2345).
All 1H and 13C NMR spectroscopic data were in total agreement with
the literature (Figures S13, S15, S17, and S18).6,9
+20.4 (c 0.06 in CHCl3). Fuscol (lit.): [α]D = +21.0 (c 0.9 in CHCl3).8b
See Figures S13−S16 for a comparison of 1H and 13C NMR spectra.
In Vivo Mouse Ear Edema Assay. The assay was completed by
Amplia PharmaTek Inc. as previously described by Martinez et al.10 The
6−7-week-old female CD-1 mice (Charles River Canada Inc.) were pro-
vided with food and water ad libitum and acclimatized for at least 5 days.
PMA (100 μg/mL, n = 6), indomethacin (150 mg/mL, n = 6), and
diterpenes 1−3 (5 mg/mL, n = 3) were formulated in acetone (PMA)
and DMSO (indomethacin and diterpenes). Initially, the right ears were
treated with DMSO (20 μL, vehicle control), indomethacin (3 mg in
20 μL of DMSO), or diterpene (100 μg in 20 μL of DMSO), while the
left ears received vehicle (20 μL of DMSO). One hour later, the
phlogistic agent, PMA (2 μg, 20 μL of acetone), was administered by
topical application to the right ears and the left ears received vehicle
(20 μL of acetone). Edema was measured at 6 and 24 h post-PMA
treatment using a digital caliper and calculated by subtracting the
thickness of the left ear from the right ear. The data are given as the
mean SEM in terms of percent reduction of edema. The statistical
significance of the comparison between test groups and the PMA
control was assessed by Student’s unpaired t-test. A p value < 0.05 was
considered to indicate statistical significance.
Isolation of Eunicidiol (1). Eunicidiol (1) was present in the
hexanes/EtOAc (4:1) fraction and collected alongside 2 and 3 during
the above-mentioned C18 RP-MPLC separation. The compound was
purified by a combination of phenylhexyl RP-HPLC (MeOH/H2O,
77:23, 3.0 mL/min, tR 31.1 min) and C18 RP-HPLC (MeOH/H2O,
80:20, 3.0 mL/min, tR 21.5 min) to provide a colorless oil (1, 1.5 mg).
Eunicidiol (1): [α]25D = −33.4 (c 0.02 in MeOH); IR νmax 3357, 3064,
3039, 2971, 2925, 2857, 1645, 1450, 1385, 1371, 1149, 1021, 968, 899;
HRESIMS m/z 327.2286 [M + Na]+ (calcd for C20H32O2Na,
327.2295). NMR spectroscopic data (Figures S1−S8) are summarized
in Table 1.
Synthesis of (R)- and (S)-MPA Esters of Eunicidiol (6 and 7). A
solution containing eunicidiol (1) (100 μg, 0.33 μmol), DMAP (3.8 mg,
31.1 μmol), DCC (20.0 mg, 96.9 μmol), and 3 Å molecular sieves was
stirred in freshly distilled DCM (3 mL) under an N2 atmosphere for
20 min. Subsequently, an excess of (R)-or (S)-MPA (13.8 mg, 83.0 μmol)
ASSOCIATED CONTENT
* Supporting Information
NMR spectra and MS data for diterpenes 1−3 and MPA esters 6
and 7 are available. This material is available free of charge via the
■
S
AUTHOR INFORMATION
■
Corresponding Author
*Tel: +1 902 566 0565. Fax: +1 902 566 7445. E-mail: rkerr@
Notes
The authors declare no competing financial interest.
1292
dx.doi.org/10.1021/np300149y | J. Nat. Prod. 2012, 75, 1289−1293